Skip to main content
sickle cell diseaseresource center

Menu

  • Menu

Main navigation

  • Home
  • Featured Diseases & Conditions
    • COVID-19
    • Depression Care 360
    • HIV Management
    • HIV Prevention
    • Pediatric Influenza
    • Psoriatic Arthritis
  • Resources
    • Commentary
    • Disease State Directory
    • FDA Alerts
    • Pearls
    • Podcasts
    • Polls
    • Q&As
    • Quizzes
    • Research Summaries
    • Slideshows
    • Videos
  • Events & Education
    • Consultant360's Practical Updates in Primary Care
    • CME
  • Publication
    • About Consultant
    • Consultant Current Issue
    • Consultant Early View
    • Consultant Archive
    • Author Guidelines
    • Case Report Templates
    • FAQ
    • Advertising With Consultant360
Consultant 360
Search
Login

Menu

  • Menu

Main navigation

  • Home
  • Featured Diseases & Conditions
    • COVID-19
    • Depression Care 360
    • HIV Management
    • HIV Prevention
    • Pediatric Influenza
    • Psoriatic Arthritis
  • Resources
    • Commentary
    • Disease State Directory
    • FDA Alerts
    • Pearls
    • Podcasts
    • Polls
    • Q&As
    • Quizzes
    • Research Summaries
    • Slideshows
    • Videos
  • Events & Education
    • Consultant360's Practical Updates in Primary Care
    • CME
  • Publication
    • About Consultant
    • Consultant Current Issue
    • Consultant Early View
    • Consultant Archive
    • Author Guidelines
    • Case Report Templates
    • FAQ
    • Advertising With Consultant360
 

Sickle Cell Disease

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Videos

Research Summaries

sickle cell disease
sickle cell disease
L-Glutamine for Sickle Cell Disease: A Landmark FDA Approval
08/09/2018
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
08/09/2018
sickle cell disease
sickle cell disease
L-Glutamine for Sickle Cell Disease: A Landmark FDA Approval
08/03/2018
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
08/03/2018
sickle cell disease
sickle cell disease
FDA Approves New Option for Sickle Cell Disease
07/07/2017
The US Food and Drug Administration recently approved a new oral treatment for adult and pediatric patients with sickle cell disease.
07/07/2017

January 2023

Current Issue
January 2023
Volume 63
Issue 1
Current Issue > Issue Archive >
Consultant 360
RESOURCES
  • News
  • Clinical Insights
  • Interactive Features
JOURNAL
  • Current Issue
  • Issue Archive
  • Author Guidelines
  • Submit Your Manuscript
ABOUT
  • Editorial Description
  • Section Editors
  • Contact Us
  • Email Alerts
  • Create Account
STAY CONNECTED
  • Email Alerts
  • Create Account
© 2023 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use